Eric K. Rowinsky

Eric K. Rowinsky



Dr. Eric K. Rowinsky is a Oncologist in New York, NY. Find Dr. Rowinsky ‘s phone number, address and more.

Eric K. Rowinsky , M.D.

is the Executive Chairman of Rgenix and Chair of its Clinical Advisory Board. Dr. Rowinsky is principally focused on the comprehensive development and registration strategies of cancer therapeutics of all types.

Eric K. Rowinsky , MD, is the Executive Chairman of Rgenix and Chair of its Clinical Advisory Board. Dr. Rowinsky is principally focused on the comprehensive development and registration strategies of cancer therapeutics of all types.

6/18/2020  · Eric Rowinsky biography. Dr. Eric K. Rowinsky , M.D. is an Independent Director of Biogen Inc. Dr. Rowinsky has served as President of RGenix, Inc.

a privately-held life sciences company, since November 2015 and as its Executive Chairman since December 2016. Since June 2016 Dr. Rowinsky has also been the Chief Scientific Officer of Clearpath Development Co.

which rapidly advances.

Eric K. Rowinsky founded Primrose Therapeutics, Inc. Currently, Dr. Rowinsky is Executive Chairman of Rgenix, Inc.

Chairman at Kitov Pharma Ltd. and Chief Scientific Officer at Clearpath Development Co. Dr. Rowinsky is also on the board of 7 other companies.

Eric K. Rowinsky , MD, is the Executive Chairman of Rgenix and Chair of its Clinical Advisory Board. Dr. Rowinsky is principally focused on the comprehensive development and registration strategies of cancer therapeutics of all types.

Eric has made over 12 trades of the Biogen stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 10,824 units of BIIB stock worth $170,694 on 27 April 2015. Eric Rowinsky Net Worth (2020) | wallmine, 6/18/2020  · Eric Rowinsky biography. Dr. Eric K. Rowinsky , M.D. is an Independent Director of Biogen Inc. Dr. Rowinsky has served as President of RGenix, Inc.

a privately-held life sciences company, since November 2015 and as its Executive Chairman since December 2016. Since June 2016 Dr. Rowinsky has also been the Chief Scientific Officer of Clearpath Development Co.

which rapidly advances …

Advertiser